In summary, we showed that HMGCS2 expression and βHB concentration are regulated by the Wnt/β-catenin/PPARγ pathway in human intestinal cancer cell lines and mouse intestinal organoid cultures. This evidence concerns the gene HMGCS2 and intestinal cancer.